CVI 2020 Webinar Series: Complication Management
October 1, 2020 – October 1, 2021
This activity has been designed to meet the educational needs of cardiologists, surgeons, internists, trainees, investigators, and allied health care workers who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases.
The goal of this activity is to provide participants with knowledge on how to evaluate and treat patients with coronary artery disease, peripheral vascular disease, and valvular, structural heart and arrhythmic heart disease.
- Describe various complications of percutaneous coronary interventions
- Examine strategies to prevent complications
- Discuss complication management approaches and algorithms
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Cardiovascular Innovations Foundation. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.
The CMEsolutions designates this enduring internet activity for a maximum of 1 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Start Date - End Date
October 1, 2020 - October 1, 2021
There is no registration fee for this activity.
- View webinar
- At the end of the webinar, login to:
- Complete the Evaluation/Credit Request Form-No credit requests will be accepted after October 1, 2021
- Download or Print Credit Statement
FACULTY AND DISCLOSURES
CMEsolutions requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMEsolutions for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. CMEsolutions has resolved all conflicts of interest prior to this educational activity.
Mazen Abu Fadel, MD, FACC, FSCA
Clinical Professor of Medicine, Oklahoma Heart Hospital North Campus
Oklahoma City, OK
Mazen Abu Fadel has no relevant financial relationships to disclose.
Emmanouil S. Brilakis, MD, PhD
Director, Center for Complex Coronary Interventions, Minneapolis Heart institute
Emmanouil Brilakis has disclosed the following relevant financial relationships: Abbott Vascular, Boston Scientific, CSI, GE Healthcare-Consultant, Speaker's Bureau; Amgen, Infra Redx, Teleflex-Speaker Bureau; Regeneron, Siemens Healthineers-Research Grant, Speaker's Bureau; Elsevier-Consultant
Allison Hall, MD
Interventional Cardiologist, Clinical Assistant Professor of Medicine, Eastern Health, Memorial University of Newfoundland
Allison Hall has no relevant financial relationships to disclose.
Robert F. Riley, MD, MS
Research and Medical Director, Complex Coronary Therapeutic Program, The Christ Hospital Health System
Robert Riley has disclosed the following relevant financial relationships: Medtronic, Boston Scientific, Asah Intecc-Consultant, Speaker’s Bureau
Yader Sandoval, MD
Assistant Professor of Medicine, Interventional Cardiologist, Mayo Clinic
La Crosse, WI
Yader Sandoval has no relevant financial relationship to disclose.
No member of CMEsolutions or Cardiovascular Innovations Foundation has any relevant financial relationships to disclose in regards to this activity.
This activitymay contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA. Please consult the prescribing information for each product.
Commercial Support for this educational activity will be provided by the following:
- Boston Scientific